256 related articles for article (PubMed ID: 3620017)
1. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
Tripathi HL; Vocci FJ; Brase DA; Dewey WL
Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
[TBL] [Abstract][Full Text] [Related]
2. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
[TBL] [Abstract][Full Text] [Related]
3. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
Hillard CJ; Harris RA; Bloom AS
J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
[TBL] [Abstract][Full Text] [Related]
4. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
Reichman M; Nen W; Hokin LE
Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
Poddar MK; Dewey WL
J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
[TBL] [Abstract][Full Text] [Related]
6. Effect of cannabinoids on the turnover rate of acetylcholine in rat hippocampus, striatum and cortex.
Revuelta AV; Moroni F; Cheney DL; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):107-10. PubMed ID: 703853
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
9. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
Reichman M; Nen W; Hokin LE
Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi ES; Green MR; Martin BR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1002-9. PubMed ID: 2162942
[TBL] [Abstract][Full Text] [Related]
11. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
[TBL] [Abstract][Full Text] [Related]
12. Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey.
Carney JM; Balster RL; Martin BR; Harris LS
J Pharmacol Exp Ther; 1979 Sep; 210(3):399-404. PubMed ID: 113528
[TBL] [Abstract][Full Text] [Related]
13. Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice.
Watanabe K; Yamamoto I; Oguri K; Yoshimura H
Drug Metab Dispos; 1981; 9(3):261-4. PubMed ID: 6113937
[TBL] [Abstract][Full Text] [Related]
14. Interaction between impulse-flow and delta 9-tetrahydrocannabinol within the septal-hippocampal cholinergic pathway of rat brain.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1981 Nov; 219(2):580-4. PubMed ID: 6270316
[TBL] [Abstract][Full Text] [Related]
15. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
Hillard CJ; Pounds JJ; Boyer DR; Bloom AS
J Pharmacol Exp Ther; 1990 Mar; 252(3):1075-82. PubMed ID: 2156989
[TBL] [Abstract][Full Text] [Related]
16. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
Shook JE; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):444-9. PubMed ID: 2542532
[TBL] [Abstract][Full Text] [Related]
17. Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1',2'-dimethyl-heptyl homolog.
Revuelta AV; Cheney DL; Costa E; Lander N; Mechoulam R
Brain Res; 1980 Aug; 195(2):445-52. PubMed ID: 6249445
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
[TBL] [Abstract][Full Text] [Related]
19. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.
Ozaita A; Puighermanal E; Maldonado R
J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726
[TBL] [Abstract][Full Text] [Related]
20. In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to Delta-tetrahydrocannabinol.
Butovsky E; Juknat A; Goncharov I; Elbaz J; Eilam R; Zangen A; Vogel Z
J Neurochem; 2005 May; 93(4):802-11. PubMed ID: 15857384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
